Fredrik N. Albach

Suggest Changes
Learn More
The CD40–CD40L pathway is a promising treatment target for autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and lupus nephritis. The safety, pharmacokinetics and(More)
  • 1